rs7649466

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_170662.5(CBLB):​c.-280G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000246 in 1,054,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )

Consequence

CBLB
NM_170662.5 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0320

Publications

13 publications found
Variant links:
Genes affected
CBLB (HGNC:1542): (Cbl proto-oncogene B) This gene encodes an E3 ubiquitin-protein ligase which promotes proteosome-mediated protein degradation by transferring ubiquitin from an E2 ubiquitin-conjugating enzyme to a substrate. The encoded protein is involved in the regulation of immune response by limiting T-cell receptor, B-cell receptor, and high affinity immunoglobulin epsilon receptor activation. Studies in mouse suggest that this gene is involved in antifungal host defense and that its inhibition leads to increased fungal killing. Manipulation of this gene may be beneficial in implementing immunotherapies for a variety of conditions, including cancer, autoimmune diseases, allergies, and infections. [provided by RefSeq, Sep 2017]
CBLB Gene-Disease associations (from GenCC):
  • autoimmune disease, multisystem, infantile-onset, 3
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.19).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_170662.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CBLB
NM_170662.5
MANE Select
c.-280G>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 19NP_733762.2
CBLB
NM_170662.5
MANE Select
c.-280G>T
5_prime_UTR
Exon 1 of 19NP_733762.2
CBLB
NM_001321788.2
c.-104G>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 19NP_001308717.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CBLB
ENST00000394030.8
TSL:1 MANE Select
c.-280G>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 19ENSP00000377598.4
CBLB
ENST00000394030.8
TSL:1 MANE Select
c.-280G>T
5_prime_UTR
Exon 1 of 19ENSP00000377598.4
CBLB
ENST00000405772.5
TSL:2
c.-280G>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 16ENSP00000384938.1

Frequencies

GnomAD3 genomes
AF:
0.000106
AC:
16
AN:
150742
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00299
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000481
GnomAD4 exome
AF:
0.0000111
AC:
10
AN:
903966
Hom.:
0
Cov.:
30
AF XY:
0.0000141
AC XY:
6
AN XY:
424292
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
16068
American (AMR)
AF:
0.00
AC:
0
AN:
2246
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
6510
East Asian (EAS)
AF:
0.00195
AC:
8
AN:
4106
South Asian (SAS)
AF:
0.00
AC:
0
AN:
31886
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
4226
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1898
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
806034
Other (OTH)
AF:
0.0000645
AC:
2
AN:
30992
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.520
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000106
AC:
16
AN:
150868
Hom.:
0
Cov.:
32
AF XY:
0.000122
AC XY:
9
AN XY:
73706
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41352
American (AMR)
AF:
0.00
AC:
0
AN:
15180
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3452
East Asian (EAS)
AF:
0.00300
AC:
15
AN:
5004
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4716
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10352
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67520
Other (OTH)
AF:
0.000476
AC:
1
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
89

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.19
CADD
Benign
17
DANN
Benign
0.93
PhyloP100
0.032
PromoterAI
0.014
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7649466; hg19: chr3-105587845; API